Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Lightfoot, Linda J., d/b/a Universal Direct, and Charles F. Childs
Sound City 2000, Inc., and Linda M. Simmons., U.S. (for the FTC)
Walker, David L., d/b/a DLW Consulting, Inc.
Sunbelt Construction Co
Garrett, Paula L. d/b/a Discreet Data Systems
Guzzetta, Victor L., d/b/a Smart Data Systems
Hewlett-Packard Company and Compaq Computer Corporation
Vital Living Products, Inc. d/b/a American Water Service; and Donald R. Podrebarac
The marketers of a home test kit for anthrax, and an on-line seller of a colloidal silver product purported to treat anthrax, have both settled Federal Trade Commission charges of false and unsubstantiated product advertising.
Pletschke, Kris A., individually and d/b/a Raw Health, In the Matter of
A & S Pharmaceutical Corporation, In the Matter of
Pharmaceutical Formulations, Inc.
Leiner Health Products, Inc.
Stock Value 1., a/k/a SV1, and Deborah Jenkins
INA-Holding Schaeffler RG and FAG Kugelfischer Georg Schafer AG, In the Matter of
The consent order permits WA's acquisition of FAG Kugelfischer Georg Schufer AG but requires the divestiture of FAG'S cartridge ball screw support bearing business to Aktiebolaget SKF within 20 business days after the consummation of the INAJFAG transaction. According to the complaint issued with the consent order, the acquisition, as planned, would create a monopoly in the worldwide market for cartridge ball screw support bearings, a type of bearing used in the manufacture of machine tool equipment.
Roche Holding Ltd, In the Matter of
Roche agreed to divest, certain assets in the U.S. and Canada to settle antitrust concerns stemming from its proposed acquisition of Corange Limited. The consent order permits the acquisition but requires the divestiture of Cardiac thrombolytic agents (drugs used to treat heart attack victims) and ongoing business assets relating to chemicals used to test for the presence of illegal or abused drugs.